Dermatology billing is more complex than most other specialties. Industry data shows practices lose between 7% and 11% of annual revenue to preventable billing errors — for a practice billing $1.5 million per year, that is up to $165,000 walking out the door.
A single dermatology visit can generate a biopsy (CPT 11102–11107), a separate evaluation and management service (CPT 99202–99215), and a lesion destruction (CPT 17000–17111) all on one claim, all requiring independent justification, correct diagnosis linking, and the right modifiers. One error in that chain denies the entire claim or triggers a payer audit.
This guide covers the 12 most common dermatology billing challenges, including two that most practices overlook entirely: NCCI edit violations and prior authorization breakdowns — and the exact solutions to address each one.
12 Dermatology Billing Challenges
Modifier Confusion and Denials
Dermatologists use modifiers constantly. Modifier 25 for a separately identifiable evaluation and management on the same day as a procedure. Modifier 59 for distinct procedural services. Modifier 51 for multiple procedures. Modifier 76 for repeat procedures by the same physician. The list goes on.
The problem is not that dermatologists use modifiers. The problem is that they use them incorrectly or forget to use them at all. A patient comes in with a suspicious mole on the back and a separate rash on the arm. The dermatologist examines the mole, decides to biopsy it, and also evaluates the rash, prescribes a cream, and counsels the patient. The practice needs to bill for the biopsy and the evaluation and management visit. Without modifier 25 on the E/M code, the payer assumes the E/M service was included in the biopsy payment and denies it.
Another common modifier problem involves multiple procedures. A dermatologist performs three shave biopsies on three different lesions. Without modifier 59 or XS on the second and third biopsies, the payer assumes all three biopsies were done on the same lesion and pays only for one.
The Biopsy to Excision Coding Trap
Here is a scenario that happens every day in dermatology practices. A patient has a suspicious lesion. The dermatologist performs a shave biopsy to get tissue for pathology. The pathology comes back showing melanoma. The dermatologist performs an excision immediately to remove the entire lesion. The practice has two procedures on the same day on the same site. The question is how to bill them.
Patients are suspicious of same-day biopsy and excision. They worry that the biopsy was actually a partial excision and that the provider is double-billing. Without proper documentation and modifiers, the claim is denied, or the payment is reduced. Some practices have stopped performing same-day excisions entirely because the billing is too complicated. That hurts patients who need immediate treatment.
Pathology and Dermatopathology Billing Confusion
Dermatology practices send thousands of skin samples to pathology labs every year. The billing for these services gets complicated quickly. Who bills for the pathology reading? Who bills for the technical component of the slide preparation? What happens when the practice has its own in-house dermatopathologist?
Many practices lose money on pathology billing without even knowing it. They assume the lab is billing everything correctly. But missed modifiers, incorrect diagnosis links, and improper coding for multiple specimens all lead to lost revenue. A single missed technical component on a biopsy can cost the practice thirty or forty dollars. Multiply that by hundreds of biopsies per month, and the loss adds up fast.
Medical Necessity and Diagnosis Linking
Every procedure on a claim needs a diagnosis code that supports medical necessity. For a biopsy, the diagnosis must justify the need to biopsy the lesion. A diagnosis of “benign neoplasm” does not justify a biopsy because a benign neoplasm does not need to be biopsied. The diagnosis needs to be something like “neoplasm of uncertain behavior” or “skin lesion suspicious for malignancy.”
The same problem applies to excisions. A diagnosis of “seborrheic keratosis” does not justify an excision. Seborrheic keratoses are benign and do not need to be removed for medical reasons. If the patient wanted it removed for cosmetic reasons, the patient should pay out of pocket.
The diagnosis-linking problem worsens with multiple procedures on the same claim. Each procedure needs its own diagnosis code. A single diagnosis code on the claim is not enough when the patient had three biopsies on three different lesions with three different suspected diagnoses.
Split-Thickness and Full-Thickness Skin Graft Coding
Skin graft coding is notoriously complicated. The code depends on the graft’s thickness, size, location, and whether it came from the patient or another source.
A split-thickness skin graft uses code 15100 for the first 100 square centimeters. A full-thickness skin graft uses a different code, 15240, for the first 20 square centimeters. The preparation of the graft site uses additional codes. The closure of the donor site uses its own code.
Mistakes in skin graft coding are expensive. A practice that bills a full-thickness graft as a split-thickness graft loses hundreds of dollars per procedure. A practice that forgets to bill for the donor site closure loses additional revenue. A practice that misstates the size of the graft risks an audit for upcoding.
Destruction of Lesions Coding Rules
Dermatologists destroy lesions all the time. Cryotherapy, electrosurgery, and laser ablation. Each method has its own coding rules. The code depends on the number of lesions treated, the method used, and the type of lesion.
The most common mistake in lesion destruction coding is counting lesions incorrectly. CPT Code 17110 is for the destruction of up to 14 benign lesions. Code 17111 is for the destruction of 15 or more benign lesions. A practice that destroys 16 lesions and bills 17110 has undercoded, leaving money on the table. A practice that destroys 10 lesions and bills 17111 has been overcoded, creating audit risk.
Another common mistake is using destruction codes for lesions that are not benign. Premalignant lesions, such as actinic keratoses, use different codes. Malignant lesions use surgical excision codes, not destruction codes.
Mohs Surgery Coding Complexity
Mohs surgery has its own unique coding system. The code is 17311 for the first stage of Mohs surgery. Additional stages use codes 17312, 17313, and 17314 depending on the number of stages and the complexity.
The Mohs surgeon bills for the surgery itself. A separate provider bills for the pathology interpretation of the Mohs layers. The practice needs to coordinate between the surgeon and the pathologist to avoid duplicate billing.
Many practices bill Mohs surgery incorrectly because they do not understand the difference between stages and specimens. A single stage can have multiple specimens. The code is based on stages, not specimens. A practice that bills by specimen rather than by stage is overbilling and invites an audit.
Cosmetic vs. Medically Necessary Services
Dermatologists provide both cosmetic and medically necessary services. The two are not billed the same way. Medically necessary services are covered by insurance. Cosmetic services are not.
The challenge comes when a service has both cosmetic and medical components. A patient has a scar from a surgery. The scar is symptomatic, causing pain and itching. The patient also wants the scar removed for cosmetic reasons. The dermatologist excises the scar. Is the excision medically necessary or cosmetic?
The answer depends on the documentation. If the note says “patient requests scar removal for cosmetic reasons,” the service is cosmetic and not covered. If the note says “symptomatic scar causing pain and itching, excision performed for symptom relief,” the service is medically necessary and covered.
E/M Coding with Procedures on the Same Day
Evaluation and management coding on the same day as a procedure creates special challenges. The E/M service must be significant and separately identifiable from the procedure. A quick “how are you doing” before a biopsy does not count.
The documentation needs to clearly separate the E/M portion of the visit from the procedure portion. The chief complaint for the E/M should be different from the reason for the procedure. The history and exam for the E/M should be documented separately.
Many dermatologists document the E/M and the procedure together in one paragraph. That documentation does not support billing a separate E/M service. The claim gets denied, and the practice loses the E/M revenue.
Global Period and Post-Op Care Billing
Most dermatology procedures have a global period. During that global period, the payment for the procedure includes all routine post-operative care. The practice cannot bill separately for E/M services related to the procedure.
A patient has a skin cancer excision with a 10-day global period. The patient returns in 7 days for suture removal. The practice cannot bill for that suture removal visit. The payment for the excision already includes it.
The challenge comes when the patient has a new problem during the global period. A patient returns for suture removal after an excision and also mentions a new rash on the other arm. The new rash is not related to the excision. The practice can bill for evaluation of the new rash with modifier 24 appended to the E/M code.
NCCI Edit Violations in Dermatology Billing
The National Correct Coding Initiative (NCCI), maintained by CMS, defines which procedure code pairs cannot be billed together without a supporting modifier. When two codes are bundled under NCCI rules, the payer pays only for one — the higher-reimbursed code — and silently denies the other without explanation.
Three NCCI violations that hit dermatology practices most often:
- Billing CPT 17000 and CPT 17110 together without modifier 59 or XS. Treating actinic keratoses and benign warts on the same day requires a modifier on the secondary code to show the procedures were performed on separate anatomical structures. Without it, the payer bundles them and pays for one.
- Billing a biopsy and excision on the same lesion, same day, without documentation. CMS considers the biopsy included in the excision when both occur on the same lesion and same date. You can still bill both — but only with a modifier and a pathology report showing the excision was prompted by the biopsy result.
- Billing a shave removal (CPT 11300–11313) and a destruction code (CPT 17110) for the same lesion. The method of removal determines the code. You cannot bill both a removal and a destruction for the same lesion regardless of technique.
The fix: Check every multi-procedure claim against the current NCCI edit table before submission. CMS updates the table quarterly (January, April, July, October). Most billing software includes a built-in claim scrubber that flags conflicting code pairs — never override a flag without reviewing the documentation. Assign one person on your team to download updated NCCI tables each quarter and flag any new dermatology-relevant edits.
Prior Authorization Breakdowns in Dermatology Billing
When a practice performs a procedure that required prior authorization but did not obtain it, the payer denies the claim in full. Unlike a modifier error or a mislinked diagnosis — both correctable on resubmission — a prior authorization denial on an already-performed service is rarely reversible. The practice absorbs the full cost.
Procedures most frequently requiring prior authorization in dermatology:
- Biologic medications (dupilumab/Dupixent, secukinumab/Cosentyx, ixekizumab/Taltz) — Required by virtually all commercial payers and Medicare Advantage plans. Most payers also require documented step therapy failure before approving a biologic. A missing step-therapy note or a nonspecific ICD-10 code — L40 instead of L40.0 (plaque psoriasis) — will delay or deny the authorization entirely.
- Phototherapy (CPT 96910–96913, narrowband UVB and PUVA) — Most commercial payers require authorization plus a documented treatment failure history before approving a course of phototherapy.
- Mohs surgery on non-facial sites (CPT 17311–17315) — Many payers limit Mohs authorization to high-risk histologic subtypes or specific anatomical locations. Always verify requirements by plan, not just by payer.
- Laser treatments for medical indications — Vascular laser for port-wine stains and ablative laser for symptomatic scar revision require authorization from most payers. The distinction between cosmetic and medical intent must be clearly documented in the authorization request.
The fix: Assign one person to own prior authorization — not a distributed team responsibility. Build a one-page matrix listing every contracted payer, which procedures require authorization, and typical turnaround time. For biologics, submit the authorization request at the point of prescribing, not after the pharmacy calls with a denial. Track every open authorization in your practice management system with a five-business-day follow-up trigger. If authorization was in process before the date of service, document this — some payers will retroactively approve when a timely request is on record.
Dermatology CPT Code Quick Reference
Use this table at the billing desk before claim submission. Always verify the specific code within each range against the size, depth, and location in the clinical note.
| Procedure | CPT Range | Key Modifier | Most Common Error |
| Shave (tangential) biopsy | 11102–11103 | 59 / XS | No modifier on second biopsy |
| Punch biopsy | 11104–11105 | 59 / XS | Not differentiating from incisional |
| Incisional biopsy | 11106–11107 | 59 / XS | Using shave code for deep biopsy |
| Excision — benign | 11400–11471 | 59 / XS | Wrong code when pathology uncertain |
| Excision — malignant | 11600–11646 | 59 / XS | Size based on pre-excision, not post |
| Skin tag removal | 11200–11201 | None | Billing per lesion, not per group |
| Destruction — premalignant (AK) | 17000–17004 | 59 | Using benign code 17110 for AK |
| Destruction — benign lesions | 17110–17111 | 59 / XS | Miscounting lesions; wrong threshold |
| Mohs — first stage | 17311 | None | Billing by specimen, not stage |
| Mohs — additional stages | 17312–17314 | None | Wrong add-on for stage count |
| Split-thickness skin graft | 15100–15101 | 59 | Omitting add-on for grafts >100 sq cm |
| Full-thickness skin graft | 15240–15241 | 59 | Missing donor site closure code |
| E/M same day as procedure | 99202–99215 | 25 | Missing modifier 25 |
| E/M during global period (new problem) | 99202–99215 | 24 | Missing modifier 24 |
| Phototherapy | 96910–96913 | None | Submitting without prior authorization |
Medicare note: Replace modifier 59 with XS (separate structure) on all Medicare and Medicare Advantage multi-procedure dermatology claims.
How to Address Dermatology Billing Challenges
Create a Modifier Cheat Sheet for Your Practice
The best way to prevent modifier errors is to put the rules right in front of your providers and billers. Create a one-page cheat sheet that lists the most common modifiers, when to use each one, and the documentation required.
Post the cheat sheet in every exam room. Put a copy at every billing desk. Review it at monthly staff meetings. When a provider is documenting a note, the cheat sheet is right there, reminding them to add modifier 25 to the E/M code and modifier 59 to the second biopsy.
The cheat sheet should include examples. “Use modifier 25 when the patient has a rash and a biopsy. Document the rash evaluation separately from the biopsy decision.” “Use modifier 59 when performing biopsies on two different lesions. Document the location of each lesion.”
Train billers to check for modifiers before submitting claims. A biller who sees a claim with two biopsies and no modifier should send it back to the provider for correction before submission.
Implement a Same-Day Biopsy and Excision Protocol
Do not leave same-day biopsy and excision decisions to individual provider judgment. Create a practice-wide protocol that everyone follows.
The protocol should require the provider to document the biopsy separately from the excision. The biopsy note should describe the initial lesion and the reason for the biopsy. The excision note should describe the pathology results that prompted the excision. The timing should be clear. “Biopsy performed at 9 AM. Pathology read at 10 AM. Excision performed at 10:30 AM.”
On the claim, bill the biopsy with modifier 59 or XS. Bill the excision with its own code. Include the pathology report with the claim if the payer allows electronic attachments. Some payers require a copy of the pathology report to prove that the excision was medically necessary based on biopsy results.
If a payer has a history of denying same-day biopsy and excision claims, consider scheduling the excision for a different day. The patient may not love coming back, but the practice will get paid without having to fight appeals.
Audit Your Pathology Billing Monthly
Run a report of all pathology and dermatopathology claims from the past month. Review every claim for common errors.
Check that each biopsy specimen has a corresponding pathology code. Check that the pathology code includes both the technical and professional components when appropriate. Check that multiple specimens are billed with modifier 59. Check that the diagnosis on the pathology claim matches the diagnosis on the biopsy claim.
If the practice has its own in-house dermatopathologist, review the supervision and documentation requirements. The dermatopathologist must bill under their own NPI for the professional component. The practice can bill for the technical component under the practice’s NPI.
Assign one person in the practice to own the pathology billing. That person should review every pathology claim before submission. That person should track denial patterns and work with the lab to correct systemic issues.
Build Diagnosis Linking into Your Documentation Workflow
The easiest way to ensure proper diagnosis linking is to build it into the documentation template. Require providers to list each procedure and link it to a specific diagnosis in the same line of the note.
Instead of writing “Three biopsies performed on the back” at the end of the note, write “Biopsy of lesion on left upper back for rule out BCC. Biopsy of the lesion on the right lower back to rule out SCC. Biopsy of lesion on mid back to rule out dysplastic nevus.”
This documentation tells the biller exactly which diagnosis goes with which procedure. The biller can link diagnosis A to procedure A, diagnosis B to procedure B, and diagnosis C to procedure C without guessing.
Train billers to check diagnosis links before submitting claims. A claim with three biopsies and only one diagnosis code should be returned to the provider for correction.
Use a Skin Graft Coding Worksheet
Skin graft coding has too many variables to memorize. Create a worksheet that walks providers and billers through the coding decision.
The worksheet should ask the following questions.
- Is the graft split-thickness or full-thickness?
- What is the size of the graft in square centimeters?
- What is the location of the graft?
- Is the donor site from the same patient or a different source?
Based on the answers, the worksheet directs the user to the correct codes. For a 50-square-centimeter split-thickness graft on the leg, the worksheet directs coding 15100 for the first 100 square centimeters. For a 30-square-centimeter full-thickness graft on the face, the worksheet directs 15240 for the first 20 square centimeters and 15241 for each additional 20 square centimeters.
Keep the worksheet at the billing desk. When a claim comes in with skin graft codes, the biller runs it through the worksheet to verify correctness.
Train Staff on Lesion Counting
Lesion destruction coding depends entirely on accurate counting. Providers need to count every treated lesion and clearly document the count.
Train providers to write the number of lesions in the note. “Cryotherapy performed on 12 actinic keratoses on the face and scalp.” Not “multiple lesions treated.” Not “several lesions.” The exact number.
Train billers to check the documented number against the code billed. 14 or fewer benign lesions use code 17110. 15 or more benign lesions use code 17111. The biller should catch any mismatch before the claim goes out.
For premalignant lesions such as actinic keratoses, the codes differ. Code 17000 is for the first lesion. Code 17003 is for lesions 2 through 14. The biller needs to know the difference between benign and premalignant codes.
Coordinate Between Mohs Surgeon and Pathologist
Mohs surgery billing requires coordination between the surgeon and the pathologist. The practice needs a clear process for determining who bills what.
The Mohs surgeon bills the surgical codes. 17311 for the first stage. 17312 for each additional stage up to 5 stages. The surgeon does not bill for the pathology interpretation. That is the pathologist’s role.
The pathologist bills for the pathology interpretation of the Mohs layers. The pathologist uses the same stage numbers to identify how many layers were read.
The practice should have a standing agreement with the pathologist about who bills what. The agreement should be in writing. The billers for both practices should communicate regularly to ensure no duplicate billing.
Use Specific Cosmetic Exclusion Language in Documentation
The best way to prevent cosmetic denials is to document medical necessity clearly. Use specific language that leaves no doubt.
For a symptomatic scar, write “Patient reports pain and itching at scar site for 6 months. Scar is tender to palpation. Excision performed for symptom relief.” Not “Patient requests scar removal.”
For a lesion that the patient wants removed for cosmetic reasons, write “Patient requests removal of lesion for cosmetic reasons. The lesion is asymptomatic. No medical indication for removal. Patient advised that insurance will not cover this service. Patient signed a cosmetic waiver.”
Have patients sign a cosmetic waiver before performing purely cosmetic services. The waiver should state that the patient understands insurance will not pay and that the patient is personally responsible for the full cost.
Separate E/M and Procedure Documentation
Train billers to document the E/M portion of the visit separately from the procedure portion. Use headings in the note to create a clear separation.
Write “E/M Assessment” at the start of the note. Under that heading, document the chief complaint, history, and exam for the E/M service. Write “Procedure” later in the note. Under that heading, document the procedure and the findings specific to the procedure.
This documentation structure makes it easy for billers and auditors to see that the E/M service was significant and separately identifiable from the procedure. A claim with this documentation is much less likely to be denied.
For the claim, append modifier 25 to the E/M code. Submit the E/M code and the procedure code together. The payer will see the modifier and the separate documentation and pay both.
Track Global Periods in Your Practice Management System
Your practice management system should automatically track global periods. When a patient has a procedure with a global period, the system should flag any E/M claim submitted during that period.
The flag should trigger a review. Does the E/M service relate to the procedure? If yes, the claim should not be billed. Is the E/M service for a new problem unrelated to the procedure? If yes, append modifier 24 and bill the claim.
Train billers to manually review every global period flag. Do not rely on the system to make the decision automatically. The system cannot read the note to determine whether the E/M service is for a new problem or related to the procedure.
For procedures with zero-day global periods, no flag is needed. The practice can bill E/M services on the same day as the procedure with modifier 25.
Conclusion
Dermatology billing errors are predictable, which means they are preventable. The practices that succeed are the ones that stop treating billing as an afterthought and start treating it as a core clinical process. Implement the solutions in this guide one at a time. Start with the problem that costs you the most money. Fix that, then move to the next.
Take Control of Your Dermatology Billing Today
If you need help implementing these solutions, UControl Billing is here to help.
We specialize in dermatology billing services. We know the modifiers. We know the pathology rules. We know the diagnosis linking requirements. We have helped dozens of dermatology practices reduce denials and increase revenue.
Contact UControl Billing
Frequently Asked Questions
Can a dermatologist bill an E/M code and a procedure code on the same day?
Yes, but only if the E/M service is significant and separately identifiable from the procedure. Append modifier 25 to the E/M code. Document the E/M service separately from the procedure. Without modifier 25, the payer will deny the E/M code.
How do I bill for multiple biopsies on the same day?
Bill the first biopsy with the base code. Bill each additional biopsy with modifier 59 or XS appended. Document the location of each biopsy in the note. For Medicare, use the XS modifier instead of modifier 59 for different structures.
What is the difference between modifier 59 and the X modifiers?
Modifier 59 is the older, less specific modifier. The X modifiers are more specific. XE is for a separate encounter. XS is for a separate structure. XP is for a different practitioner. XU is for unusual non-overlapping service. For dermatology, XS is the most commonly used. Medicare prefers the X modifiers over modifier 59.
Can I bill for a same-day biopsy and excision?
Yes, but the documentation must be clear. Document the biopsy and the pathology results separately from the excision. Bill the biopsy with modifier 59 or XS. Bill the excision with its own code. Include the pathology report with the claim if possible.
How do I bill for a skin graft?
The code depends on the thickness and size of the graft. For split-thickness grafts, use 15100 for the first 100 square centimeters. For full-thickness grafts, use 15240 for the first 20 square centimeters. Bill, the donor site closure is separate. Use a worksheet to ensure correct coding.
What are NCCI edits and how do they affect dermatology billing?
NCCI edits are CMS rules that define which procedure code pairs cannot be billed together without a modifier. In dermatology, the most common violations involve billing premalignant and benign destruction codes together, or billing a biopsy and excision on the same lesion without documented justification. Append modifier 59 (or XS for Medicare) to the secondary procedure code and ensure the note supports separate, distinct services on separate structures.
Which dermatology procedures typically require prior authorization? Biologic medications, phototherapy (CPT 96910–96913), Mohs surgery on non-facial sites, and laser treatments for medical indications most commonly require prior authorization. Requirements vary by payer and individual plan. Always verify by plan before scheduling — not just by payer name. A prior authorization denial on a completed procedure is rarely recoverable on appeal.
What is the difference between CPT 17000 and CPT 17110? CPT 17000 covers destruction of the first premalignant lesion (actinic keratosis). CPT 17003 is the add-on for each additional premalignant lesion through 14, and CPT 17004 covers 15 or more premalignant lesions. CPT 17110 covers destruction of up to 14 benign lesions. These families are not interchangeable. Using 17110 for actinic keratoses is a coding error that triggers denials and audit flags.
What ICD-10 codes matter most in dermatology billing? L57.0 (actinic keratosis) supports CPT 17000–17004. D48.5 (neoplasm of uncertain behavior of skin) supports biopsy when malignancy cannot be ruled out. L90.5 (scar conditions and fibrosis) supports excision when symptomatic. L40.0 (plaque psoriasis) supports biologic authorization. Using a nonspecific code — such as L82.1 (seborrheic keratosis) to justify a surgical excision — is one of the top medical necessity denial triggers in dermatology.
Should a dermatology practice outsource billing or keep it in-house? Both models work, but the decision depends on claim volume and coding complexity. In-house billing gives direct control over documentation and denial feedback loops. Outsourcing to a dermatology-specialized billing company eliminates the ongoing training burden on CPT updates, NCCI edit changes, and payer policy shifts — and brings denial rate benchmarks from across multiple practices. Practices billing more than 300 claims per month typically see a net revenue improvement after moving to a dermatology-specific billing partner.
